4//SEC Filing
Costa Carlos 4
Accession 0001562180-24-006859
CIK 0001822462other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:01 PM ET
Size
14.4 KB
Accession
0001562180-24-006859
Insider Transaction Report
Form 4
Costa Carlos
Chief People Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-16$3.72/sh+400$1,488→ 400 total - Sale
Common Stock
2024-09-16$10.00/sh−400$4,000→ 0 total - Exercise/Conversion
Common Stock
2024-09-17$3.72/sh+10,272$38,212→ 10,272 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-16−400→ 98,248 totalExercise: $3.72Exp: 2029-02-12→ Common Stock (400 underlying) - Sale
Common Stock
2024-09-17$10.04/sh−10,272$103,131→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-17−10,272→ 87,976 totalExercise: $3.72Exp: 2029-02-12→ Common Stock (10,272 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.18 per share.
- [F3]The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001939167
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:01 PM ET
- Size
- 14.4 KB